StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
34
Publishing Date
2023 - 11 - 25
1
2023 - 03 - 15
1
2023 - 02 - 07
1
2023 - 02 - 06
1
2022 - 12 - 09
1
2022 - 12 - 08
1
2022 - 11 - 16
1
2022 - 11 - 04
2
2022 - 10 - 12
1
2022 - 09 - 26
1
2022 - 08 - 31
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 07 - 27
1
2022 - 06 - 29
1
2022 - 06 - 25
1
2022 - 06 - 17
1
2022 - 05 - 24
1
2022 - 05 - 23
1
2022 - 04 - 29
1
2022 - 04 - 14
1
2022 - 03 - 29
1
2022 - 03 - 15
2
2022 - 01 - 19
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 12 - 09
1
2021 - 11 - 22
1
2021 - 11 - 19
1
2021 - 10 - 29
1
2021 - 10 - 13
1
2021 - 09 - 10
1
Sector
Communications
34
Health technology
25
Manufacturing
1
Process industries
1
Tags
Acquisition
75
America
56
Award
48
Awards
91
Business
73
California
164
Cancer
138
Care
44
Citrus
44
Conference
152
Corporation
54
Day
50
Designation
42
Energy
165
Europe
53
Expansion
52
Expected
43
Fda
63
Financial
182
Food
56
Global
217
Group
102
Growth
185
Health
163
Home
71
International
44
Life
44
Management
50
Market
1012
Medical
66
Meeting
97
Mobile
60
N/a
6832
Network
52
One
46
Order
45
Partnership
83
Patent
84
Platform
43
Program
80
Reach
575
Report
251
Research
729
Results
330
Sales
69
Service
66
Services
136
Smart
53
Solar
48
Solutions
50
Study
43
System
71
Technology
86
Therapeutics
66
Treatment
84
Trial
66
Update
64
Water
81
Work
47
Year
158
Entities
Biontech se
23
Elanco animal health incorporated
1
Gritstone oncology, inc.
1
Immunitybio inc
1
Novartis ag
1
Orange
34
Pfizer, inc.
22
Sanofi
24
Zoetis inc.
1
Symbols
ABT
10
ACIU
10
AGEN
13
ALPMF
7
ALPMY
7
AMRS
8
ANIX
24
APDN
9
ARCT
18
ARVL
31
AZN
29
AZNCF
19
BNTX
111
BWV
20
CMXHF
7
CNC
8
CSLLY
7
CVAC
25
CVS
12
DVAX
82
DYAI
17
EBS
15
EVAX
17
FNCTF
34
GLAXF
35
GOVX
32
GRTS
23
GSK
56
IBRX
10
ICVX
7
INO
22
JNJ
327
LLY
8
MRK
20
MRNA
142
NRXP
11
NVAX
132
NVS
16
NVSEF
10
OCGN
25
ORMP
11
PAHC
9
PCVX
10
PDSB
9
PFE
106
SNGX
12
SNY
258
SNYNF
163
SRNE
8
STRO
9
TAK
27
TMO
8
TNXP
26
TSN
8
VAXX
9
VBIV
64
VCNX
34
VIR
9
VXRT
44
ZTS
9
Exchanges
Nasdaq
34
Nyse
23
Crawled Date
2023 - 11 - 25
1
2023 - 03 - 15
1
2023 - 02 - 07
1
2023 - 02 - 06
1
2022 - 12 - 09
1
2022 - 12 - 08
1
2022 - 11 - 17
1
2022 - 11 - 04
2
2022 - 10 - 12
1
2022 - 09 - 26
1
2022 - 08 - 31
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 07 - 27
1
2022 - 06 - 29
1
2022 - 06 - 25
1
2022 - 06 - 17
1
2022 - 05 - 24
1
2022 - 05 - 23
1
2022 - 04 - 29
1
2022 - 04 - 14
1
2022 - 03 - 29
1
2022 - 03 - 15
2
2022 - 01 - 19
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 12 - 09
1
2021 - 11 - 22
1
2021 - 11 - 19
1
2021 - 10 - 29
1
2021 - 10 - 13
1
2021 - 09 - 10
1
Crawled Time
00:00
1
08:20
1
09:00
1
11:00
7
12:00
2
13:00
1
13:20
1
13:30
2
14:00
2
14:20
1
15:00
2
15:20
1
16:00
1
16:20
1
17:00
2
18:00
4
20:00
1
21:00
1
22:00
1
23:00
1
Source
www.biospace.com
6
www.globenewswire.com
21
www.nantkwest.com
1
www.prnewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Vaccine
symbols :
Fnctf
save search
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published:
2023-11-25
(Crawled : 08:20)
- prnewswire.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
ELAN
|
$13.41
-1.69%
-0.45%
4.1M
|
Process Industries
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
ZTS
|
News
|
$151.94
-0.71%
2.38%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
vaccine
reach
research
market
Gritstone bio Announces Presentations on Neoantigen Prediction Capabilities and Cancer Vaccine Programs at the 2023 AACR Annual Meeting
Published:
2023-03-15
(Crawled : 11:00)
- globenewswire.com
GRTS
|
$0.7448
-3.51%
-3.64%
3.1M
|
Health Technology
|
-71.04%
|
O:
-1.54%
H:
1.96%
C:
0.0%
meeting
vaccine
cancer
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at the 2023 AACR Annual Meeting
Published:
2023-02-07
(Crawled : 09:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
meeting
vaccine
program
mrna
presentation
cancer
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at the 2023 AACR Annual Meeting
Published:
2023-02-06
(Crawled : 13:20)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
2.65%
|
O:
-7.26%
H:
5.82%
C:
5.82%
meeting
vaccine
program
mrna
presentation
cancer
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
Published:
2022-12-09
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.47%
|
O:
-0.89%
H:
0.0%
C:
0.0%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-50.91%
|
O:
-0.06%
H:
2.11%
C:
-0.06%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.54%
|
O:
-0.15%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-49.75%
|
O:
-0.05%
H:
0.75%
C:
-0.83%
covid-19
fda
designation
candidate
vaccine
influenza
fast track designation
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published:
2022-12-08
(Crawled : 16:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
12.43%
|
O:
-0.76%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.83%
|
O:
0.5%
H:
0.16%
C:
0.16%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-49.4%
|
O:
-0.12%
H:
3.36%
C:
3.19%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.83%
|
O:
-1.32%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-46.91%
|
O:
0.37%
H:
5.31%
C:
5.26%
covid-19
fda
children
vaccine
authorization
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
Published:
2022-11-16
(Crawled : 00:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
6.71%
|
O:
-1.22%
H:
0.0%
C:
0.0%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-47.1%
|
O:
-0.52%
H:
1.45%
C:
1.11%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
4.13%
|
O:
-2.28%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-47.64%
|
O:
-1.45%
H:
2.36%
C:
2.31%
covid-19
candidate
vaccine
study
Gates Biomanufacturing Facility Announces Manufacture of Recombinant Protein - Alzheimer's Disease Vaccine for Institute for Molecular Medicine's Clinical Trials
Published:
2022-11-04
(Crawled : 15:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
18.92%
|
O:
4.93%
H:
0.0%
C:
0.0%
trials
disease
alzheimer's
vaccine
molecular
Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine
Published:
2022-11-04
(Crawled : 11:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
18.92%
|
O:
4.93%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
6.86%
|
O:
-0.02%
H:
0.43%
C:
0.43%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-45.42%
|
O:
1.93%
H:
0.15%
C:
-0.53%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
8.67%
|
O:
2.05%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-40.56%
|
O:
7.6%
H:
0.33%
C:
-1.27%
covid-19
vaccine
response
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
Published:
2022-10-12
(Crawled : 15:00)
- globenewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-39.36%
|
O:
0.41%
H:
2.49%
C:
-0.14%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
17.42%
|
O:
0.76%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-33.32%
|
O:
3.4%
H:
4.91%
C:
2.06%
covid-19
fda
children
vaccine
authorization
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
Published:
2022-09-26
(Crawled : 11:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
26.36%
|
O:
5.77%
H:
0.0%
C:
-2.27%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-42.33%
|
O:
-0.61%
H:
1.19%
C:
0.05%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
20.14%
|
O:
-2.29%
H:
0.35%
C:
-0.67%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-32.73%
|
O:
-1.21%
H:
4.5%
C:
0.67%
fda
children
vaccine
application
authorization
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
Published:
2022-08-31
(Crawled : 14:20)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
16.37%
|
O:
0.75%
H:
1.98%
C:
1.98%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-44.56%
|
O:
0.35%
H:
0.6%
C:
-1.7%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
11.94%
|
O:
1.1%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-41.3%
|
O:
0.63%
H:
1.42%
C:
-2.27%
covid-19
fda
vaccine
granted
authorization
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
Published:
2022-08-23
(Crawled : 11:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
6.42%
|
O:
-0.87%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
10.96%
|
O:
1.75%
H:
0.0%
C:
0.0%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-48.02%
|
O:
-0.98%
H:
0.21%
C:
-0.85%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
11.84%
|
O:
-0.72%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-41.78%
|
O:
0.13%
H:
1.14%
C:
-0.84%
covid-19
children
vaccine
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
Published:
2022-08-22
(Crawled : 15:20)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
14.44%
|
O:
1.54%
H:
1.57%
C:
1.57%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-48.28%
|
O:
0.12%
H:
0.38%
C:
-0.63%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
12.14%
|
O:
0.27%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-41.63%
|
O:
-0.79%
H:
2.56%
C:
1.06%
covid-19
fda
vaccine
application
authorization
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
Published:
2022-07-27
(Crawled : 11:00)
- globenewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-51.4%
|
O:
-0.69%
H:
0.61%
C:
0.02%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.48%
|
O:
-0.24%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-45.94%
|
O:
-0.13%
H:
0.0%
C:
-2.28%
covid-19
candidate
vaccine
study
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
Published:
2022-06-29
(Crawled : 21:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-6.98%
|
O:
1.06%
H:
0.0%
C:
0.0%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-49.94%
|
O:
1.79%
H:
2.31%
C:
1.43%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.31%
|
O:
-4.58%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-39.19%
|
O:
3.2%
H:
4.97%
C:
1.76%
covid-19
vaccine
agreement
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
Published:
2022-06-25
(Crawled : 16:20)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
covid-19
vaccine
response
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
Published:
2022-06-17
(Crawled : 14:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-4.95%
|
O:
-4.49%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-4.59%
|
O:
-1.76%
H:
5.75%
C:
5.5%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-46.85%
|
O:
-0.74%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.07%
|
O:
1.39%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-33.15%
|
O:
0.78%
H:
0.0%
C:
0.0%
covid-19
fda
children
vaccine
authorization
emergency use authorization
PharmaJet Partner, Institute for Molecular Medicine, Launches Clinical Trial for the First in Human Alzheimer’s DNA Vaccine
Published:
2022-05-24
(Crawled : 18:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
vaccine
dna
trial
alzheimer’s
molecular
alzheimer's
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
Published:
2022-05-23
(Crawled : 11:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-17.6%
|
O:
-3.11%
H:
0.0%
C:
0.0%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-50.41%
|
O:
2.55%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.75%
|
O:
1.61%
H:
0.0%
C:
0.0%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-48.55%
|
O:
-0.85%
H:
0.06%
C:
-1.91%
covid-19
children
vaccine
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.